Comments
Loading...
Omega Therapeutics Analyst Ratings and Price Targets | OTC:OMGAQ | Benzinga
Omega Therapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Omega Therapeutics Corp from these most-recent analyst ratings.
Analyst Ratings for Omega Therapeutics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Omega Therapeutics (OMGAQ) stock?
There is no price target for Omega Therapeutics
What is the most recent analyst rating for Omega Therapeutics (OMGAQ)?
There is no analyst for Omega Therapeutics
When was the last upgrade for Omega Therapeutics (OMGAQ)?
There is no last upgrade for Omega Therapeutics
When was the last downgrade for Omega Therapeutics (OMGAQ)?
There is no last downgrade for Omega Therapeutics.
When is the next analyst rating going to be posted or updated for Omega Therapeutics (OMGAQ)?
There is no next analyst rating for Omega Therapeutics.
Is the Analyst Rating Omega Therapeutics (OMGAQ) correct?
There is no next analyst rating for Omega Therapeutics.
Browse analyst ratings and price targets on all stocks.
